Q4 2023 Cytosorbents Corp Earnings Call TranscriptGuruFocus • about 2 months ago
Related Stocks: NAS:CTSO...
Share to Feed
CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript...
STAR-T trial results selected for a Breakout Presentation at the American Association of Thoracic Surgery Annual Meeting in late-April 2024 CytoSorbents intends to submit DrugSorb-ATR for regulatory...
PRINCETON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
PRINCETON, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cytosorbents Corporation ( Cytosorbents or the Company ) (NASDAQ: CTSO). Such investors...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cytosorbents Corporation ( Cytosorbents or the Company ) (NASDAQ: CTSO). Such investors...